Among NON DM and IFG subjects, RVO incidence increased along with the BMI, but in all MED DM subjects, those with a DM duration of less than 5 years and more than 5 years who had been using insulin or oral hypoglycemia medications at baseline, RVO incidence decreased as BMI increased. This evidence concerns the gene INS and diabetes mellitus.